The global increase in the cancer burden has significantly increased the need for flow cytometry-based products to conduct screening and therapeutic monitoring during cancer treatment. Flow cytometry is one of the well established screening methods in the field of oncology and immunology, which enables healthcare professionals to define cell types in a heterogeneous cell population through the analysis of underlying cellular expressions. Primary immunodeficiencies (PIDs) are a diverse set of immune system hereditary disorders. Genetic screening provides an effective diagnosis of PID; however, it is time-consuming and costly. Flow cytometry possesses a rapid and effective tool for the diagnosis of PIDs.
Flow Cytometry in Oncology and Immunology Market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032. The market is driven by factors such as the increasing burden of cancer, expansion of applications in flow cytometry for research activities, innovation in flow cytometry leading to the use of next-generation flow cytometers, and the increasing use of flow cytometry in the identification and diagnosis of immune-deficiency diseases.
Market Segmentation:
Segmentation 1: by Offering
• Products
o Instruments
o Reagents and Consumables
o Software
• Services
The global flow cytometry in oncology and immunology market (by offering) is expected to be dominated by the products segment.
Segmentation 2: by Technology
• Cell-Based Flow Cytometry
• Bead-Based Flow Cytometry
The global flow cytometry in oncology and immunology (by technology) is expected to be dominated by the cell-based flow cytometry segment.
Segmentation 3: by Type
• Immunology
• Oncology
The global flow cytometry in oncology and immunology market (by type) is dominated by the oncology segment.
Segmentation 4: by Application
• Translational Research
• Clinical Research
The global flow cytometry in oncology and immunology market (by application) is dominated by the translational research segment.
Segmentation 5: by End User
• Hospitals, Diagnostic Laboratories, and Reference Laboratories
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others
The global flow cytometry in oncology and immunology market (by end user) is dominated by the hospitals, diagnostic laboratories, and reference laboratories segment.
Segmentation 6: by Region
• North America - U.S., Canada
• Europe - Germany, France, U.K., Italy, Spain, Netherlands, Rest-of-Europe
• Asia-Pacific - Japan, China, India, Australia, South Korea, Singapore, Rest-of-Asia-Pacific
• Latin America - Brazil, Mexico, Rest-of-Latin America
• Rest-of-the-World
The global flow cytometry in oncology and immunology market (by region) is dominated by the North America segment.
Some of the players in this market are:
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Cell Signalling Technology, Inc.
• Cytek Biosciences, Inc.
• Danaher Corporation
• DiaSorin S.p.A (Luminex Corporation)
• Enzi Biochem Inc.
• Laboratory Corporation of America Holdings
• Merck KGaA
• Miltenyi Biotec
• NeoGenomics Laboratories, Inc.
• OPKO Health, Inc.
• Sony Group Corporation
• Thermo Fisher Scientific Inc
COVID-19 Impact and Post-COVID-19 Scenario
The initial breakout of the pandemic led to an increase in the use of reagents of flow cytometry in research activities and clinical trials. The current market assessment has considered information provided by key opinion leaders in the market from both supply and demand sides. In the post-COVID-19 phase, it is expected that with the restrictions gradually being removed from several regions around the world, coupled with research activities resuming normalcy, the market will face a low impact on the annual revenue generation.
Flow Cytometry in Oncology and Immunology Market to Grow Despite Challenges
Some of the key challenges to the growth of the global flow cytometry in oncology and immunology market include the huge capital investment and the difficulty associated with operating the flow cytometry instruments. However, overcoming these challenges poses an opportunity for the market to continue to grow rapidly. Some of the key barriers to the growth of the market and possible solutions to overcome them have been listed in the following table
Get Free Sample Report - https://bisresearch.com/requestsample?id=1399&type=download
Key Questions Answered in the Report
What are the major market drivers, challenges, and opportunities in the global flow cytometry in oncology and immunology market’?
What are the emerging trends within the global flow cytometry in oncology and immunology market?
How is each segment of the global flow cytometry in oncology and immunology market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2032?
What are the significant developmental strategies implemented by the major players to sustain in the competitive market?
Who are the leading players with significant offerings to the global flow cytometry in oncology and immunology market?
What is the current market dominance for each of these leading players?
What is the expected compound annual growth rate (CAGR) expected to be witnessed by the leading players in the market during the forecast period 2022-2032?
Which application are anticipated to have the most promising growth?
Who are the key manufacturers in the global flow cytometry in oncology and immunology market, and what are their contributions?
What is the growth potential of the global flow cytometry in oncology and immunology market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World?
What is the global flow cytometry in oncology and immunology market segmentation by type?
Additionally, BIS Research also offers a dedicated and unique platform to find and access deeptech insights and updates on emerging technologies across industry verticals. Insight Monk, an AI powered deeptech search engine, is a subscription based platform that offers a library of latest market insights and updates based on emerging tech. Learn more about InsightMonk here. https://www.insightmonk.com
